Debabrata Mitra

  • Citations Per Year
Learn More
CONTEXT Altered fractionated radiotherapy may have better result than conventional radiotherapy and concomitant chemoradiotherapy to treat locally advanced head and neck cancers. AIMS Evaluation of the response and toxicities in different fractionated radiotherapy schedules in locally advanced head and neck cancer. MATERIALS AND METHODS Sixty four(More)
The aim of the present study is to analyse the cases of male breast carcinoma as regards its incidence, family history, clinical presentation, staging, histopathological grade, hormone receptor status and to identify the prognostic significance of the above factors on the final outcome. Seventy-nine cases of male breast carcinoma were treated in the(More)
Cutaneous B cell lymphoma (CBCL) is a lymphoproliferative disorder of neoplastic B cell of the skin. These are rarer than T cell lymphomas. Commonly, the presenting features of CBCL are plaques or nodules. Here is a case report of CBCL with a very unusual presentation of cutaneous horns. The patient was managed by a combination chemotherapy and local(More)
Carcinoma cervix is the commonest female malignancy in India. In advanced stages radiotherapy was the only treatment options available. Recently there is interest in chemotherapy but the combination, dosage and timing are not well standardised. With this background a trial was undertaken to evaluate the role of chemotherapy along with radiotherapy in(More)
INTRODUCTION The worldwide incidence of breast cancer has increased rapidly in recent years. The scenario of Eastern India is also showing the same trend. It is necessary to study the utility of HER-2/neu as a prognostic factor in breast cancer survival. However, there have not been detailed studies in this respect with the breast cancer patients of Eastern(More)
OBJECTIVE To study the efficacy of neo-adjuvant chemotherapy followed by radiotherapy in advanced head and neck cancer. STUDY DESIGN Randomised, prospective study. SETTING Tertiary academic referral center. PATIENTS One hundred and eighty patients of advanced head and neck squamous cell carcinoma. INTERVENTION PATIENTS were randomized into two arms.(More)
  • 1